“A key advantage of ioMicroglia for us is the low inter-lot variability, which ensures consistent assay performance and facilitates long-term, and large-scale screening studies.”

"With our solid iPSC expertise, we were thrilled to find a cellular model that aligns seamlessly with our drug screening efforts. ioOligodendrocyte-like cells performed reliably and met all expectations. We especially appreciated bit.bio's detailed protocols and excellent scientific support, which made integration into our workflow both smooth and productive."